Log in or Sign up for Free to view tailored content for your specialty!
Practice Management News
CAR T-cell therapy brings sustained, drug-free remission in three autoimmune diseases
Single injections of CD19 chimeric antigen receptor T-cell therapy brought long-lasting remission to 15 patients with three different autoimmune diseases, according to data published in The New England Journal of Medicine.
Urticarial Vasculitis: Attack of the Nettles, Part 1
Is it an allergy or an autoimmune vasculitis, or a little of both? Find out the story of urticarial vasculitis, how this disease was recognized and eventually sorted out from other types of urticaria.
Log in or Sign up for Free to view tailored content for your specialty!
‘We want to work with you’: Physiatry referrals can help fatigue in autoimmune diseases
SCOTTSDALE, Ariz. — Physical medicine and rehabilitation play an important role in recovering from fatigue symptoms in immune-mediated diseases, according to a speaker at the Basic and Clinical Immunology for the Busy Clinician symposium.
VIDEO: ‘So much’ placebo power can be harnessed to treat rheumatology patients
In this Healio video exclusive, Leonard Calabrese, DO, chief medical editor of Healio Rheumatology, discussed the top items from the February issue, including an exploration of how the placebo effect can be applied in rheumatology.
FDA approves Simlandi as third interchangeable Humira biosimilar
The FDA has approved Simlandi as the third interchangeable biosimilar to Humira following a rejection in April 2023 stemming from issues at the developer’s manufacturing facility.
‘Exploring the power of their mind’: Data may offer clues to harnessing the placebo effect
Despite the placebo effect’s long history in medicine — not to mention the critical role placebo plays in randomized trials — the mechanism driving it remains poorly understood.
Rheumatology meets placebo-nocebo science: At last!
I am thrilled to introduce our cover story this month, “‘Exploring the Power of Their Mind’: Data May Offer Clues to Harnessing the Placebo Effect,” to the readers of Healio Rheumatology. I say this for several reasons.
Rule streamlining prior authorization is a step forward for primary care, 'but not a leap'
The new CMS rule aiming to streamline prior authorization signals a major step forward for primary care, but the process could still use some improvement, according to experts.
Better grasp of how guidelines develop may help overcome ‘unhelpful,’ ‘outdated’ stigma
SCOTTSDALE, Ariz. — Understanding how guidelines and recommendations are formed can make them “most helpful” in clinical practice, according to a presentation at the Basic and Clinical Immunology for the Busy Clinician symposium.
‘Ubiquitous’ COVID-19 may help rheumatologists understand integrated immune response
SCOTTSDALE, Ariz. —The COVID-19 pandemic could enable better understanding of the relationship between infection and autoimmunity, according to a speaker at the Basic and Clinical Immunology for the Busy Clinician symposium.
-
Headline News
VIDEO: Surface attacks in health care will be a ‘source of constant vulnerability’
January 02, 20256 min watch -
Headline News
National Kidney Foundation consensus: Race-free eGFR may optimize decision-making
January 09, 20252 min read -
Headline News
Cannabis use, schizophrenia genetic predisposition both independently raise psychosis risk
January 06, 20252 min read
-
Headline News
VIDEO: Surface attacks in health care will be a ‘source of constant vulnerability’
January 02, 20256 min watch -
Headline News
National Kidney Foundation consensus: Race-free eGFR may optimize decision-making
January 09, 20252 min read -
Headline News
Cannabis use, schizophrenia genetic predisposition both independently raise psychosis risk
January 06, 20252 min read